Frequency of chronic venous insufficiency in patients of Schamberg’s disease
Keywords:
Schamberg’s disease, chronic venous insufficiency, Doppler ultrasound, frequency, varicose veinsAbstract
Objective To determine the frequency of chronic venous insufficiency in patients of Schamberg’s disease. Methodology The study was cross-sectional & conducted in Dermatology outpatient department at Saifee Hospital Trust, Karachi, Pakistan. The duration of study was eleven months i.e. from April 2017 to March 2018. Clinically diagnosed, 60 cases of Schamberg’s disease were included via non probability consecutive sampling technique. Age of patients was 18 years and above. Clinical examination for varicose veins and Doppler ultrasonography of the lower extremities were performed and findings were recorded. Results In our study, the mean age was 44.43±13.83 years. Out of 60 patients, 27 (45%) were male and 33 (55%) were female. Only 13 (21.67%) patients had a positive family history of Schamberg’s disease. In our study, 18 (30%) patients had clinically detected varicose veins of lower limbs while variable degrees of venous insufficiency were detected in 28 (46.67%) patients on Doppler ultrasound of the lower extremities. Conclusion The number of patients with chronic venous insufficiency in Schamberg’s disease is significantly higher and it might be one of the main predisposing factors for this disease. However, further case-control studies are required to calculate its prevalence and to confirm its aetiopathogenic association.ÂReferences
Haddad CJ, Lacle JH, Haddad CM. An uncommon cause of skin discoloration: Purpura Pigmentosa Progressiva. Int J Pathol Clin Res 2015; 1: 11-2.
Torrelo A, Requena C, Mediero IG, Zambrano A. Schamberg'spurpura in children: a review of 13 cases. J Am Acad Dermatol 2003; 48: 31-3.
Tristani-Firouzi P, Meadows KP, Vanderhooft S. Pigmented purpuric eruptions of childhood: a series of cases and review of literature. Pediatr Dermatol 2001; 18: 299–304.
Sardana K, Sarkar R, Sehgal VN. Pigmented purpuric dermatoses: an overview. Int J Dermatol 2004; 43: 482–8.
Leslie AT. Purpura. In: Griffiths CEM, Barker J, Bleiker T, Chalmers R, Creamer D, editors. Rook’s textbook of dermatology. Vol 4. 9th ed Oxford: Wiley-Blackwell; 2016 p. 101.1-101.27.
Schetz D, Kocić I. A new adverse drug reaction: Schamberg’s disease caused by amlodipine administration – a case report. Br J Clin Pharmacol 2015; 80(6): 1477-8.
Cavalcante MLLL, Masuda PY, Brito FF, Pinto ACVD, Itimura G, Nunes AJF. Schamberg’s disease: case report with therapeutic success by using colchicine. An Bras Dermatol 2017; 92(2): 246-8.
Kim SK, Kim EH, Kim YC. Treatment of pigmented purpuricdermatosis with topical photodynamic therapy. Dermatology 2009; 219: 184–6.
Manolakos DA, Weiss J, Glick B, Weiss KD, Weiss E. Treatment of Schamberg’s disease with advanced fluorescence technology. J Drugs Dermatol 2012; 11(4): 528–9.
Geller M. Benefit of colchicine in the treatment of Schamberg’s disease. Ann Allergy Asthma Immunol 2000; 85(3): 246.
Hilerowicz Y, Sprecher E, Gat A, Artzi O. Successful treatment of Schamberg’s disease with fractional non-ablative 1540 nm erbium:glass laser. J Cosmet Laser Ther 2018; 16: 1-4.
Sharma L, Gupta S. Clinicoepidemiological study of pigmented purpuricdermatoses. Indian Dermatol Online J 2012; 3: Shimizu H. Pigmented purpuricdermatosis in mixed cryoglobulinaemia associated with rheumatoid arthritis and hepatitis C infection. Acta Derm Venereol 2005; 85(5): 460-1.
Raslan HM, Ezzat WM, Abd El Hamid MF, Emam H, Amre KS. Skin manifestations of chronic hepatitis C virus infection in Cairo, Egypt. East Mediterr Health J 2009; 15(3): 692-70.
Tato BP, Marinero Escobedo S, Pérez González YC, Sánchez Albisua B, PolimónOlabarrieta I, Encabo Mayoral B. Granulomatous variant of pigmented purpuricdermatosis. Am J Dermatopathol 2012; 34(7): 746-8.
Kim DH, Seo SH, Ahn HH, Kye YC, Choi JE. Characteristics and clinical manifestations of pigmented purpuric dermatoses. Ann Dermatol 2015; 27(4): 404-10.
Chatterjee S. Schamberg disease: uncommon reaction to a common drug. CMAJ 2009; 181(12): E275.
Gönül M, Çakmak SK, Özcan N, Oğuz ID, Gül U, Bıyıklı Z. Clinical and laboratory findings of pigmented purpuricdermatoses. Ann Dermatol 2014; 26(5): 610-4.
Galeandro AI, Quistelli G, Scicchitano P, Gesualdo M, Zito A, Caputo P, et al. Doppler ultrasound venous mapping of the lower limbs. Vasc Health Risk Manag 2012; 8: 59-64.
Barron GS, Jacob SE, Kirsner RS. Dermatologic complications of chronic venous disease: medical management and beyond. Ann Vasc Surg 2007; 21(5): 652-62.
Parsi K. Dermatological manifestations of venous disease: part 1. Aust N Z J Phlebology 2007; 10(1): 7-15.
Simon DA, Dix FP, McCollum CN. Management of venous ulcers. BMJ 2004; 328: 1358-62.
Cho JH, Lee JD, Kang H, Cho SH. The clinical manifestations and etiologic factors of patients with pigmented purpuric dermatoses. Korean J Dermatol 2005; 43: 45-52.
